<DOC>
	<DOCNO>NCT00754351</DOCNO>
	<brief_summary>This study evaluate efficacy toxicity docetaxel , gemcitabine bevacizumab combination , administer biweekly , salvage treatment patient metastatic HER2 negative breast cancer .</brief_summary>
	<brief_title>Docetaxel , Gemcitabine Bevacizumab Metastatic Breast Cancer</brief_title>
	<detailed_description>Docetaxel plus gemcitabine active combination salvage treatment metastatic breast cancer . Administered every two week , combination favorable toxicity profile , promise activity &gt; 1st line treatment metastatic breast cancer . Recently , initial therapy metastatic breast cancer paclitaxel plus bevacizumab demonstrate prolonged progression-free survival , compare paclitaxel alone . This study evaluate addition bevacizumab biweekly regimen docetaxel gemcitabine salvage therapy metastatic breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Histologically cytologically confirm metastatic breast adenocarcinoma No HER2 overexpression gene amplification At least one previous chemotherapy regimen metastatic breast cancer Age ≥18 year Performance status ( WHO ) 02 Life expectancy least 12 week Measurable disease define least 1 bidimensionally measurable lesion ≥ 20 X 10 mm Performance status ( WHO ) 02 Adequate liver function ( serum bilirubin &lt; 1.5 time upper normal limit , AST ALT &lt; 2.5 time upper normal limit absence demonstrable liver metastasis , &lt; 5 time upper normal limit presence liver metastasis ) , adequate renal function ( serum creatinine &lt; 1.5 time upper normal limit ) bone marrow ≥ 1,500/mm3 , PLT ≥ 100,000/mm3 , Hgb ≥ 9 g/dL ) function Written inform consent Pregnant lactate woman Progressive brain metastasis accord clinical radiological criterion Brain metastasis without prior radiation therapy Radiation therapy within previous 4 week Previous radiation therapy measurable lesion Proteinuria ≥ 500 mgr protein daily Uncontrolled hypertension Documented hemorrhagic diathesis coagulation disorder Cardiovascular disease ( class IIIV NYHA congestive heart failure , myocardial infarction within previous 4 month , unstable angina , LVEF &lt; normal , ventricular arrhythmia , uncontrolled hypertension ) Thrombotic event within previous 6 month Concurrent use aspirin &gt; 325 mgr daily , low molecular weight heparin therapeutic dose , warfarin acenocoumarol , nonsteroid antiinflammatory agent Major surgical procedure within previous 4 week Presence nonhealing wound fracture Peripheral neuropathy &gt; grade 2 accord NCI CTCAE ( version 3.0 ) Any sustained chronic toxicity &gt; grade 2 accord NCI CTCAE ( version 3.0 ) Uncontrolled infection Any serious , uncontrolled comorbidity investigator 's judgment Other cancer within previous 5 year , except nonmelanoma skin cancer situ cervical cancer Serious psychiatric illness</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>docetaxel</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>chemotherapy</keyword>
</DOC>